3-(2,4-dimethoxybenzylidene)anabaseine and quinuclidines

3-(2,4-dimethoxybenzylidene)anabaseine has been researched along with quinuclidines in 1 studies

Compound Research Comparison

Studies (3-(2,4-dimethoxybenzylidene)anabaseine)	Trials (3-(2,4-dimethoxybenzylidene)anabaseine)	Recent Studies (post-2010) (3-(2,4-dimethoxybenzylidene)anabaseine)	Studies (quinuclidines)	Trials (quinuclidines)	Recent Studies (post-2010) (quinuclidines)
166	8	81	2,567	453	991

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hashimoto, K	1

Reviews

1 review(s) available for 3-(2,4-dimethoxybenzylidene)anabaseine and quinuclidines

Article	Year
Targeting of α7 Nicotinic Acetylcholine Receptors in the Treatment of Schizophrenia and the Use of Auditory Sensory Gating as a Translational Biomarker. Current pharmaceutical design, 2015, Volume: 21, Issue:26 Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Antipsychotic Agents; Benzylidene Compounds; Biomarkers; Evoked Potentials, Auditory; Humans; Pyridines; Quinuclidines; Schizophrenia; Sensory Gating; Thiadiazoles	2015

Article

Year

Targeting of α7 Nicotinic Acetylcholine Receptors in the Treatment of Schizophrenia and the Use of Auditory Sensory Gating as a Translational Biomarker.

Current pharmaceutical design, 2015, Volume: 21, Issue:26

Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Antipsychotic Agents; Benzylidene Compounds; Biomarkers; Evoked Potentials, Auditory; Humans; Pyridines; Quinuclidines; Schizophrenia; Sensory Gating; Thiadiazoles

2015